Literature DB >> 16652302

HIV type 2 demyelinating encephalomyelitis.

Antoine Moulignier1, Caroline Lascoux, Anne Bourgarit.   

Abstract

A human immunodeficiency virus (HIV) type 2 (HIV-2)-infected African patient developed inflammatory demyelinating lesions of the optic nerves, spinal cord, and brain, which coincided with a decreasing CD4 cell count and with active HIV-2 replication. This case provides evidence that HIV-2 is neurotropic, extends the range of known HIV-2-associated neurological complications, and confirms the overlap between the neurological complications of HIV type 1 and HIV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652302     DOI: 10.1086/503909

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Emerging infections of the central nervous system.

Authors:  Jennifer Lyons; Justin McArthur
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

2.  Acute motor axonal neuropathy in HIV infection.

Authors:  Shruti Jadhav; Mukesh Agrawal; Surbhi Rathi
Journal:  Indian J Pediatr       Date:  2013-09-21       Impact factor: 1.967

3.  PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy.

Authors:  Fabian Sierra Morales; Carlos Illingworth; Kathie Lin; Ivia Rivera Agosto; Chloé Powell; Jacob A Sloane; Igor J Koralnik
Journal:  J Neurovirol       Date:  2017-08-22       Impact factor: 2.643

Review 4.  Update on human immunodeficiency virus (HIV)-2 infection.

Authors:  Omobolaji T Campbell-Yesufu; Rajesh T Gandhi
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

5.  Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.

Authors:  Youngjee Choi; John Townend; Tim Vincent; Irfan Zaidi; Ramu Sarge-Njie; Assan Jaye; David B Clifford
Journal:  J Neurovirol       Date:  2011-03-22       Impact factor: 2.643

6.  HIV-2 diagnosis and quantification in high-risk patients.

Authors:  Philip A Chan; Sarah E Wakeman; Timothy Flanigan; Susan Cu-Uvin; Erna Kojic; Rami Kantor
Journal:  AIDS Res Ther       Date:  2008-08-14       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.